Skip to main content

Polaris Partners — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

186
Companies
$6.7B
Total invested
$51.6M
Avg. check
35
Industries
Biotechnology 13Health Care 13Medical 9Therapeutics 7Pharmaceutical 4Software 4+29 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121144 of 186
Matter Neuroscience
February 2024

Over millions and millions of years, a collection of reward systems

Neuroscience · Boulder$26.0M Seed
Lyndra Therapeutics
December 2023

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

Biotechnology · Watertown$101.0M Series E
Tome Biosciences
December 2023

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Biotechnology · Watertown$213.0M Series A
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Gossamer Bio
July 2023

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Biotechnology · San Diego$212.0M Post Ipo Equity
CubicPV
June 2023

CubicPV is a solar manufacturing company that produces wafers and tandem modules.

Environmental Consulting · Bedford$33.0M Series Unknown
Cyclerion Therapeutics
May 2023

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Biotechnology · Cambridge$5.0M Post Ipo Equity
Larkspur Biosciences
May 2023

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

Biotechnology · Watertown$35.5M Series A
Kallyope
May 2023

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Biotechnology · New York$8.2M Grant
Morphic Therapeutic
May 2023

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Biotechnology · Waltham$276.0M Post Ipo Equity
QurAlis
March 2023

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Biotechnology · Cambridge$88.0M Series B
Paratus Sciences
February 2023

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

Biotechnology · New York$100.0M Series A
Faro Health
February 2023

Faro Health is a company that handles the tedious work better left for a computer.

Health Care · La Jolla$20.0M Series A
August Bioservices
December 2022

August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.

Biotechnology · Nashville$65.0M Series B
Podimetrics
November 2022

Podimetrics is a care management company with the leading solution to help prevent diabetic foot amputations.

Diabetes · Somerville$25.0M Debt Financing
Jnana Therapeutics
November 2022

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Biotechnology · Boston$107.0M Series C
Armorblox
September 2022

Armorblox uses deep learning and natural language technologies to protect enterprise communications.

Artificial Intelligence (AI) · SunnyvaleSeries Unknown
Oui Therapeutics
August 2022

Oui Therapeutics is built on science shown to help people manage troubling thoughts.

Health Care · New Haven$26.0M Series A
FidoCure
July 2022

One Health Company specializes in transforming canine cancer care through AI-driven precision medicine.

Health Care · Palo AltoSeries Unknown
SQZ Biotech
March 2022

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Biotechnology · Watertown$2.0M Grant
Satellite Bio
March 2022

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Biopharma · Cambridge$82.5M Series A
Novi Connect
February 2022

Novi is the data infrastructure platform that helps CPG brands get their products recommended in AI commerce.

Agentic AI · Larkspur$40.0M Series B
Sonrai Security
October 2021

Sonrai Security delivers enterprise cloud security for companies running on AWS, Azure, and Google Cloud.

Cloud Data Services · New York$50.0M Series C
B12
October 2021

B12 offers website building, contact management, online scheduling, payments, invoicing, and SEO services.

E-Commerce · New York$15.7M Series A

Where Polaris Partners invests

Biotechnology13
Health Care13
Medical9
Therapeutics7
Pharmaceutical4
Software4

About Polaris Partners's portfolio

How many companies has Polaris Partners invested in?

Polaris Partners has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Polaris Partners invest in?

Polaris Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 35 different industry categories.

What is Polaris Partners's largest investment?

Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post Ipo Equity round. Polaris Partners's total known invested capital is $6.7B.

What is the average investment size for Polaris Partners?

Polaris Partners's average investment size is $51.6M across its portfolio of 186 companies.

What are Polaris Partners's most recent investments?

Recent Polaris Partners portfolio additions include Matter Neuroscience, Lyndra Therapeutics, Tome Biosciences, Tisento Therapeutics, Gossamer Bio. These companies were founded in 2020 or later.

Reach the founders behind these 186 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →